Sims Andrew John Hugh MacIntyre

Average Profitability
<0.0001%
Insider Buys Quantity
8
Insider Buys Sum
$32,980.56
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Sims Andrew John Hugh MacIntyre

According to the SEC Form 4 filings, Sims Andrew John Hugh MacIntyre, being in a position of

  1. Chief Financial Officer at Plus Therapeutics, Inc.,
    оver the last 12 months, has bought 9000 shares for $15,205, and sold 0 shares,
    over all time since 2021-07-27, has bought 21230 shares for $32,981, and sold 0 shares.

The largest purchase of all time was on 2024-05-08 and amounted to 4902 shares of Plus Therapeutics, Inc. for $10,000.

Biography of Sims Andrew John Hugh MacIntyre

No biography is available at this moment.

2024-09-10PurchasePlus Therapeutics, Inc.
PSTV
Chief Financial Officer
4,098
0.0701%
$1.27$5,204+18.65%
2024-05-08PurchasePlus Therapeutics, Inc.
PSTV
Chief Financial Officer
4,902
0.103%
$2.04$10,000-23.79%
2022-04-26PurchasePlus Therapeutics, Inc.
PSTV
Chief Financial Officer
3,000
0.0009%
$0.67$2,016-30.88%
2022-03-01PurchasePlus Therapeutics, Inc.
PSTV
Chief Financial Officer
2,000
0.0006%
$1.10$2,200-53.64%
2021-11-02PurchasePlus Therapeutics, Inc.
PSTV
Chief Financial Officer
1,000
0.0005%
$1.86$1,864-57.18%
2021-10-26PurchasePlus Therapeutics, Inc.
PSTV
Chief Financial Officer
2,000
0.001%
$1.67$3,339-48.82%
2021-07-28PurchasePlus Therapeutics, Inc.
PSTV
Chief Financial Officer
2,244
0.0011%
$1.91$4,286-47.45%
2021-07-27PurchasePlus Therapeutics, Inc.
PSTV
Chief Financial Officer
1,986
0.001%
$2.05$4,071-47.18%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.